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ABSTRACT 
Background: Obesity is one of the global health problems. The prevalence of 
obesity in women is higher than men. Various metabolic problems are caused by 
obesity, such as insulin resistance and deficiency of micronutrients such as zinc. The 
occurrence of insulin resistance in obesity is also influenced by zinc deficiency 
Objective: To analyse the correlation of obesity status with serum zinc levels and 
insulin resistance in perimenopause obese women.  
Methods: Correlational research with 62 perimenopause obese women subject aged 
40-50 years old who met the inclusion and exclusion criteria. Serum zinc levels were 
measurement using AAS and insulin resistance using HOMA IR formula.  Serum 
zinc levels, fasting insulin, fasting blood glucose taken from venous blood. 
Hypothesis testing uses Pearson correlation 
Results: 12.9% had low serum zinc levels and high HOMA IR 9.09%. There was a 
significant negative correlation between BMI with serum zinc levels (r = -0.402; p = 
0.001) and significant positive correlation between BMI   with insulin resistance (r = 
0.396; p = 0.001). There was a significant negative correlation between WC with 
serum zinc levels (r = -0.18, p = 0.161) and significant positive correlation between 
WC with insulin resistance (r =0.284, p =0.025) and significant negative correlation 
between serum zinc levels with insulin resistance (r = -0.404; p = 0.001).    
Conclusion: There is a correlation between obesity status with serum zinc levels 
and correlation between obesity status with insulin resistance in perimenopause obese 
women. 
 






Obesity and excess body weight are global 
health problems as non-communicable diseases 
with an increasing tendency. Obesity is caused by 
excessive calorie intake, sedentary lifestyle, 
genetics, hormones and drugs. Obesity status is 
determined by body mass index (BMI), while  
central obesity or abdominal obesity is determined 
by body mass index (BMI), while central obesity or 
abdominal obesity is determined directly by waist 
circumference or waist circumference or waist to 
hip ratio (WHR), as well as indirectly by BIA1–5. 
The increased cardiovascular risk and mortality 
were higher due to central obesity as measured by 
BMI5. Various comorbid conditions are influenced 
by obesity status and are burdened as health 
problems of a country so that they affect health and 
socio-economic costs, so prevention is needed6.  
The prevalence of obesity in women is higher 
than men7. Energy metabolism in women is 
dominated by fat storage in an active form that has 
not been metabolized so that it tends to increase the 
distribution of fat storage, as well as higher 
circulation of leptin and adiponectin and a higher 
percentage of Subcutaneous Adipose Tissue (SAT) 
8. Adipose tissue produces various hormones that 
affect body metabolism. 
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Insulin resistance is a condition in which insulin 
is triggered to glucose uptake is disrupted in insulin-
sensitive tissues, namely in the muscles, liver and 
adipose tissue and inhibits the insulin signaling 
pathway9,10. This mechanism is influenced by factors 
such as obesity, inflammation, oxidative stress, 
hypoxia, fatty liver, hyperinsulinemia, 
hyperlipidemia, aging, mitochondrial dysfunction, 
pregnancy, lipodystrophy, endoplasmic stress 
reticulum, and genetics apart from insulin resistance, 
there is also a micronutrient deficiency in obese 
individuals that affects physiological function, 
impaired immunity and increases the risk of 
comorbidity11. One of the deficiencies of 
micronutrient that occurs in obese individuals in zinc 
deficiency12. 
Zinc is an essential trace mineral that plays a role 
in metabolism, growth and development, endocrine 
regulation, cytokine production, immune response, 
and growth of connective tissue, muscle and bone. 
The synthesis, storage and release of the hormone 
insulin into the pancreas is also assisted by zinc. Zinc 
deficiency is often found in obese people9,10. The 
interaction between Zinc Transporter * (ZnT8) which 
is dysfunction and decreasing plasma zinc 
concentration affects glucose tolerance3. Zinc affects 
glucose transport and increases peripheral insulin 
sensitivity, however there are only a few studies 
showing an association between serum zinc levels 
and insulin resistance13. Menopause is an aging 
process characterized by a transitional period of 
decreasing ovarian function and hormones14. One of 
the hormones that affects the perimenopause period 
is estrogen, which has a protective effect on insulin 
resistance. Estrogen levels in perimenopausal women 
decrease. Several studies have shown that serum 
estradiol levels have a negative correlation with 
HOMA-IR but have a positive correlation in 
postmenopausal women. Insulin resistance, impaired 
glucose metabolism and hyperinsulinemia are seen in 
men and women who are deficient in Estrogen 
Receptors (ER) and Cypq9 aromatase. 17-β-estradiol 
(E2) helps insulin work through insulin-sensitive 
tissues or indirectly with oxidative stress factors that 
trigger insulin resistance. In skeletal muscle, ER 
alpha has a positive effect on insulin signaling and the 
expression of Glucose Transporter 4 (GLUT 4), 
whereas ER beta is prodiabetogenic and reduces 
GLUT 4 expression. Based on the background 
described, the authors proposed the relationship 
between obesity status and serum zinc levels and RI 





This research was a cross-sectional study that 
carried out in PKK sub district Meteseh, 
Sendangmulyo and Lempongsari in the Semarang 
city in healthy obese perimenopause women 
population aged 40-50 years old. Subjects are  obese 
women ( BMI > 25 ), aged 40 – 50 years old, in 
menopause transition, can stand without the help of 
other people, no history or are suffering from DM 
type 2, no history or are suffering from cancer, no 
history or currently suffering from hypertension, not 
taking antipsychotic drugs (olanzapine, clozapine, 
risperidone, quetiapine, aripiprazole), not taking 
antidepressant drugs (tricylic, tetracyclic, MAOI, 
antiepileptic), bot taking hormonal drugs, steroid 
(rogestational, corticosteroid, hormonal 
contraceptives), not taking psychiatric and 
neurological drugs (ziprasidone, nortriptyline, 
nefazodone, fluvoxamine, sertraline, duloxetine, 
topiramate, zonisamide, lamotrigine)26, were 
included in the study. 
Demographic data consist of age, address, 
education, occupation, historical past illness, 
menstrual period were taken using a questionnaire. 
The diagnosis of obesity in this study used BMI 
criteria from WHO, and the risk factors for obesity 
were assessed by WC. The variables studied were: 
obesity status (BMI and WC), zinc serum levels, 
fasting blood glucose levels, fasting insulin levels 
and HOMA IR. The selection of research subjects 
was done by consecutive sampling that met the study 
inclusion criteria. Subjects were willing to take part 
in the study and sign the consent form. 
Data analysis was performed with normality test 
(Kolmogorov - Smirnov test) and correlation test 
between the variables studied using Pearson 
correlation analysis (p value <0.05, r value with 95% 
confidence interval). If the requirements are not met, 
then the Spearman correlation test is used. All data 
analysis was performed using a computer program, 
SPSS.  
3. Results 
This study was conducted on 80 subjects with 18 
subjects are drop out because they did not match the 
inclusion criteria or did not participate in the blood 
test, with details of 3 subjects who did not come for 
sampling and 15 people dropped out because of high 
blood pressure on physical examination and also high 
fasting blood glucose levels. The total number of 
respondents who can meet the requirements for this 
study is 62 subjects. 
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Table 1 Characteristics of Research Subject Data  
Parameter n (%) Mean SD (min - 
max) 
Age 
    40-45 y.o  25  
(40.32 %) 
46.19  2.87  (40.00 
- 
50.00)     45-50 y.o 37  
(59.68 %) 
Gender 
    Woman   62 
(100.00%) 
  
BMI (kg/m2)  
Obesity I  
(25-29.9) 




















SD = Standard Deviation 
 
Table 1 showed most of the subjects (98.39%) 
have waist circumference more than 80 cm. The 
mean age of subjects was 46.19 years ± 2.87, while 
based on BMI, obesity type I was 51.61% and obesity 
type II was 48.39%.  
 
Table 2 Frequency Distribution of Research Variables  
Parameter n (%) Mean SD (min-
max) 
Serum Zinc Levels (µg/dl) 
Normal  




























  Normal  
2.2 – 2.5 








1.95  1.93 (0.36 – 
11.52 ) 
SD = Standard Deviation 
 
Table 2 showed that that some respondents have 
normal serum zinc levels, 87.1%, only 12.9% have 
low serum zinc levels. Normal fasting blood glucose 
levels were 80.65%, 20% has fasting blood glucose 




Table 3 Bivariate Correlation Test Research Table  
Variables of Status 
Obesity 
Serum Zinc Levels 
 r p 
BMI -0.402 0.001 
WC -0.180 0.161 
BMI = Body Mass Index 
WC = Waist Circumference 
 
Table 3 showed that BMI had association with 
serum zinc levels with p value <0.05, WC did not 
have significant association with p>0.05.  
Table 4 showed that insulin resistance had 
significant correlation with serum zinc levels with p 
value <0.05. 
  
Table 4 Bivariate Correlation Test between serum zinc 
levels and insulin resistance  
Variable Insulin Resistance 
Serum zinc levels r p 
-0.404 0.001 
r   = correlation coefficient 
4. Discussion 
Zinc deficiency occurs in obese people. Research 
conducted on obese adults and obese children showed 
a significant reduction in serum zinc concentration3. 
The action of zinc on the pancreas is associated with 
zinc and insulin homeostasis because zinc is stored 
and secreted from the pancreas together with insulin, 
so if there is dysregulation of metabolism 
homeostasis, zinc in the pancreas hence glycemic 
control is also affected. Hyperglycemia and 
hyperinsulinemia associated with systemic blood 
glucose regulation are directly affected by zinc 
deficiency15, 16.  
Zinc plays a role in structural stability and insulin 
synthesis, in in-vitro studies of anti-diabetic potential 
and insulin mimetic zinc in experimental animals, 
found in-vitro in 1980 the formation of zinc chloride 
(ZnCl2) is similar to insulin, then further research 
found zinc deficiency in experimental animals reduce 
insulin sensitivity and zinc is associated with insulin 
action 17,18. 
Obesity is the main cause of insulin 
resistance through the ectopic accumulation 
mechanism of excessive adipocyte depots, as well as 
in liver and muscle cells due to excess energy uptake 
and reduced energy use19,20. The hypothesis that 
increased fat oxidation affects insulin resistance in 
obese states. Chronic inflammatory response is 
associated with obesity through cytokine production 
and activation of inflammatory signaling pathways. 
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The development of insulin resistance related to the 
inflammatory response in two ways, firstly by 
activating inflammatory signals mediated by IRS-1 
serine phosphorylation in sensitive cells such as 
myocytes and hepatocytes, secondly infiltration of 
inflammatory cells into adipose tissue, thereby 
altering adipocyte fat metabolism, cytokine 
production in adipose tissue19. 
Insulin resistance is influenced by signal 
transduction defects in insulin action, namely21: 
defects of insulin signaling cascade in IR/IRS-1 role, 
PKCζ/λ/ PI 3-kinase pathway, defects of GLUT4 
expression and function.22–24 Inhibitors of insulin 
signaling, inflammatory molecules and insulin 
resistance, changes in insulin receptors and role of 
IR/IGF-IR hybrid receptors. 
Glucose homeostasis is the ability to 
regulate blood glucose within normal limits. How to 
measure HOMA-IR can be done by various methods, 
with direct and indirect. Fasting blood glucose level,  
Tolerance test oral glucose (TTOG), HbA1C can 
cause disruption of glucose homeostasis.25–27 HOMA 
was first used by Mathews et all in 1985, by 
calculating with equation 28 :  
HOMA1-IR = (PIP x GDP)/22,5 
HOMA1-%B = (20xPIP)/(GDP-3,5) 
In order to know insulin resistance and beta cell 
function, where the PIP is mU/l, FBG mmol/l, if the 
unit of FBG is mg/dl then the equation:  
HOMA1-IR = (PIP x GDP)/405 
The results of correlation test showed a 
significant relationship between body mass index and 
serum zinc levels (r=-0.402, p=0.001). A negative 
correlation coefficient means that body mass index is 
inversely related to serum zinc levels. The higher the 
body mass index, the lower the serum zinc level. 
Study conducted by Zaky et al showed that serum 
zinc levels in obese subjects had an inverse 
correlation with body mass index. Body mass index 
in the obesity category showed an inverse 
relationship with zinc due to zinc and leptin 
metabolism, as evidenced by studies in mice and in 
human serum leptin levels also decreased leptin 
secretion due to reduced zinc concentrations. 
  The correlation test results showed a 
significant correlation between waist circumference 
and zinc serum levels (r= -0.18, p= 0.161). The 
negative correlation coefficient means that waist 
circumference is inversely proportional to the serum 
zinc level, the higher the waist circumference, the 
lower the serum zinc level. 
 Research by Yerlikaya et al showed that 
waist circumference in obese subjects had an inverse 
correlation with serum zinc levels. An inverse 
correlation between zinc and BMI and waist 
circumference was also found in the study of Zohal 
et al. With the limit of waist circumference ≥102 cm 
for men and ≥88 cm for women. The results of this 
study is the higher the waist circumference, the lower 
the serum zinc level, this is in accordance with the 
theory of an increase in adipose tissue mass, 
activation of the inflammatory response and obesity 
due to changes in leptin levels due to deficiency of 
certain trace minerals, one of which plays a role in 
carbohydrate metabolism and insulin action. 
The results of the correlation test showed a significant 
relationship between BMI and insulin resistance 
(r=0.396, p=0.001), weak positive correlation 
coefficient (r=0.396), meaning that BMI is directly 
proportional to insulin resistance, the higher the BMI, 
the higher the insulin resistance. Research conducted 
by Ozturk et al showed insulin as a significant 
predictor of BMI, while Okura et al showed BMI ≥23 
was a risk factor for insulin resistance and diabetes 
mellitus in Japan population. 
 The aging process is associated with insulin 
resistance, abdominal adiposity, decreased aerobic 
capacity due to reduced mass and function of heart 
and skeletal muscle cells and decreased vital 
capacity. Lifestyle with limited physical activity also 
plays a role in the aging process. Insulin mechanism 
is influenced by physical activity habit and prevents 
insulin resistance. Study conducted by Ravhette et all 
about body composition and waist circumference 
means for health risk assessment. Age, body 
composition and physical activity are also associated 
with body muscle mass and increased adiposity due 
to menopause in women and andropause in men. The 
results of correlation between BMI and insulin 
resistance in this study are in accordance with 
existing theories, and are supported by several studies 
conducted by Ozturk et al, Rachette et al and Zadeh 
et al.  
The correlation test results between waist 
circumference and insulin resistance showed a 
significant relationship (r=0.284, p=0.025). A 
positive correlation coefficient (r=0.284) means that 
waist circumference is directly proportional to insulin 
resistance. The higher the waist circumference, the 
higher the insulin resistance. 
Obesity can be determined not only by measuring 
BMI, but also by measuring BMI, but also measuring 
waist circumference to describe the distribution of 
adiposity, in the abdominal area, which correlates 
with insulin resistance. The secretion of FFA and 
adipocytokines such as TNF-α and leptin from 
adipose tissue will interfere with the insulin 
signalling system and cause insulin resistance. The 
conclusion of study by Zadeh et al that waist 
circumference was directly related to insulin 
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resistance and the cut-off value associated with 
insulin resistance was 88.5 cm for the reproductive 
age group in Iranian women. 
The correlation test between serum zinc levels 
and insulin resistance showed a significant 
correlation (r= -0.404, p= 0.001). The negative 
correlation coefficient (r= -0.404) meaning that 
serum zinc levels are inversely related to insulin 
resistance, the lower the serum zinc levels, the higher 
the insulin resistance. Study by Ranasinghe showed 
that the results of zinc supplementation reduced 
insulin resistance levels, study by Nazem et al by 
giving zinc supplementation for 8 weeks also 
decreased insulin resistance. Zinc in regulatory, 
catalytic and biological structure; mechanisms as 
cofactors and coenzymes in the homeostasis 
mechanism also plays an important role in insulin as 
a transporter out of the cytosol to enter the lumen of 
the intracellular organelles or out of cells and cellular 
signalling. The mechanism of zinc mimetic insulin 
activity on glucose and fat has been investigated that 
direct zinc transfers to the molecule as a cellular 
second messenger in glucose homeostasis and 
regulation of insulin signal via modulation of tyrosine 
kinase insulin receptor activity. 
5. Conclusion 
From the results of the study it can be concluded 
that 12.9 % have low serum zinc levels, 8.06% have 
high insulin resistance and 90.32% have low insulin 
resistance. The components of obesity status, namely 
body mass index and waist circumference, were 
associated with serum zinc levels and insulin 
resistance. Serum zinc levels with insulin resistance 
show an adequate association. 
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